Alberto J. Spindler
San Miguel De Tucuman, T, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
Journal: The Journal of rheumatology
Published: April 16, 2025
Causes and associated factors with hospitalization in patients with systemic lupus erythematosus: Data from lupus multi-center registry in Argentina.
Journal: Lupus
Published: April 05, 2025
Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial.
Journal: ACR open rheumatology
Published: March 11, 2025
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and 1-Year Analysis of a Phase 2b, Open-Label, Multicenter Study.
Journal: Arthritis care & research
Published: January 22, 2025
Active lupus in Argentina: Results of a multicenter and national registry.
Journal: Lupus
Published: November 08, 2023
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Journal: Lancet (London, England)
Published: October 26, 2022
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study.
Journal: Therapeutic advances in musculoskeletal disease
Published: February 10, 2021
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
Journal: The Journal of rheumatology
Published: January 14, 2021
Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: December 18, 2020
Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study.
Journal: The Journal of rheumatology
Published: October 28, 2020
Last Updated: 09/26/2026